Effectiveness of second generation antipsychotics: A systematic review of randomized trials
- Olanzapine. // Reactions Weekly;Dec2015, Vol. 1580 Issue 1, p276
The article describes the case of an 18-year-old male patient who developed oculogyric crisis (OGC) after being treated with olanzapine.
- Antipsychotic drug warnings indicate need for better communication between endocrinologists, psychiatrists. Milone, Angelo // Endocrine Today;Jun2010 Supplement, Vol. 8, p1
The article emphasizes the need for endocrinologists and psychiatrists to communicate better in relation to the warning issued by the U.S. Food and Drug Administration (FDA) on the adverse metabolic effects of second-generation antipsychotic drug olanzapine in adolescents.
- Olanzapine/topiramate. // Reactions Weekly;5/4/2013, Issue 1451, p38
The article describes a case of hallucinations, renal tubular acidosis and restlessness that developed in a 13-year-old adolescent girl during treatment with topiramate and olanzapine for mental disorder and epilepsy.
- Induction of manic symptoms by novel antipsychotics. Fahy, S.; Fahy, T. J. // British Journal of Psychiatry;Jun2000, Vol. 176, p597
A letter to the editor is presented which reports a case of 55-year-old woman with a 20-year history of chronic anxiety and recurrent depressive episodes who developed subjective excitement, increased psychomotor activity, insomnia, irritability and racing thoughts within three days of being...
- Olanzapine. // Reactions Weekly;2/27/2010, Issue 1290, p36
The article describes the case of two male patients who acquired tardive oculogyric crises (OGCs) while undergoing treatment with olanzapine.
- Aripiprazole/olanzapine/quetiapine. // Reactions Weekly;Dec2015, Vol. 1580 Issue 1, p47
The article describes the cases of several elderly patients who died or developed stroke after being treated with aripiprazole, olanzapine or quetiapine.
- Olanzapine. // Reactions Weekly;Dec2015, Vol. 1580 Issue 1, p275
The article describes the case of a 44-year-old male patient who developed acute pancreatitis after being treated for schizophrenia with olanzapine.
- Does Olanzapine Warrant Clinical Pharmacokineti Monitoring in Schizophrenia? Schwenger, Erin; Dumontet, Jane; Ensom, Mary H. H. // Clinical Pharmacokinetics;2011, Vol. 50 Issue 7, p415
Olanzapine, a second-generation antipsychotic, is a first-line agent in the treatment of schizophrenia. The objective of this review was to determine whether olanzapine warrants clinical pharmacokinetic monitoring in patients with schizophrenia, using a previously published decision-making...
- Effectiveness of maintenance treatments with atypical and typical antipsychotics in stable schizophrenia with early stage: 1-year naturalistic study. Guo, Xiaofeng; Fang, Maosheng; Zhai, Jinguo; Wang, Bo; Wang, Chuanyue; Hu, Bin; Sun, Xueli; Lv, Luxian; Lu, Zheng; Ma, Cui; Guo, Tiansheng; Xie, Shiping; Twamley, Elizabeth; Jin, Hua; Zhao, Jingping // Psychopharmacology;Aug2011, Vol. 216 Issue 4, p475
Rationale: The relative effectiveness of the atypical antipsychotic drugs and conventional agents in patients with early-stage schizophrenia has not been comprehensively determined. Objectives: The aim of our study was to evaluate the efficacy and safety of seven antipsychotic drugs for the...